Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maraveyas

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Cancer|February 1, 1994
Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancerA Maraveyas, D Snook, V Hird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyN Pavlidis, P Kosmidis, D Skarlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus controlR Glynne-Jones, N Counsell, P Quirke, et al.
Oncology Reports|April 4, 1998
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysisS Nicholson, C S Gooden, V Hird, et al.
Thrombosis Research|June 16, 2014
Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activityH H Echrish, Y Xiao, L A Madden, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancerA Maraveyas, J Waters, R Roy, et al.
Digestive Surgery|September 6, 2007
Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomesA Suppiah, T J White, S H Roy-Choudhury, et al.
British Journal of Cancer|February 9, 2006
Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopyD J Manton, A Chaturvedi, A Hubbard, et al.
Digestive Surgery|September 15, 2004
Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastasesT J White, S H Roy-Choudhury, D J Breen, et al.
British Journal of Cancer|August 1, 1993
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibodyV Hird, A Maraveyas, D Snook, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Cancer|February 1, 1994
Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancerA Maraveyas, D Snook, V Hird, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Subsets of tumors responsive to cisplatin or carboplatin combinations in patients with carcinoma of unknown primary site. A Hellenic Cooperative Oncology Group StudyN Pavlidis, P Kosmidis, D Skarlos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus controlR Glynne-Jones, N Counsell, P Quirke, et al.
Oncology Reports|April 4, 1998
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysisS Nicholson, C S Gooden, V Hird, et al.
Thrombosis Research|June 16, 2014
Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activityH H Echrish, Y Xiao, L A Madden, et al.
European Journal of Cancer (Oxford, England : 1990)|November 22, 2011
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancerA Maraveyas, J Waters, R Roy, et al.
Digestive Surgery|September 6, 2007
Long-term results of percutaneous radiofrequency ablation of unresectable colorectal hepatic metastases: final outcomesA Suppiah, T J White, S H Roy-Choudhury, et al.
British Journal of Cancer|February 9, 2006
Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopyD J Manton, A Chaturvedi, A Hubbard, et al.
Digestive Surgery|September 15, 2004
Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastasesT J White, S H Roy-Choudhury, D J Breen, et al.
British Journal of Cancer|August 1, 1993
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibodyV Hird, A Maraveyas, D Snook, et al.
Pageof 4